Graves' disease in Brazilian children and adults: Lack of genetic association with CTLA-4 +49A>G polymorphism

Hormone Research

Volumn 70, Issue 1, 2008, Pages 36-41

  Namo Cury, Adriano ^a,b   Longui, Carlos Alberto ^a   Kochi, Cristiane ^a   Calliari, Luiz Eduardo ^a   Scalissi, Nilza ^a   Salles, João Eduardo ^a   Neves Rocha, Mylene ^a   Barbosa De Melo, Mônica ^a   Rezende Melo, Murilo ^a   Monte, Osmar ^a  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b Santa Casa de São Paulo Endocrine and Metabologic Unit   (Brazil)

Author keywords

Children, Graves' disease; Cytotoxic T lymphocyte antigen 4 gene polymorphism; Graves' disease

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BRAZIL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENOTYPE; GRAVES DISEASE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED, 80 AND OVER; ANTIGENS, CD; AUTOANTIBODIES; BRAZIL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; GRAVES DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROXINE; TRIIODOTHYRONINE;

EID: 46349100694     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000129676     Document Type: Article

References (39)

1. Fisfalen ME, Soltani K, Kaplan E, Palmer EM, van Seventer GA, Straus FH, Diaz M, Ober C, DeGroot LJ: Evaluating the role of Th0 and Th1 clones in autoimmune thyroid disease by use of Hu-SCID chimeras. Clin Immunol Immunopathol 1997;85:253-264.
2. Heward J, Gough SC: Genetic susceptibility to the development of autoimmune disease. Clin Sci (Lond) 1997;93:479-491.
3. DeGroot LJ, Quintans J: The causes of autoimmune thyroid disease. Endocr Rev 1989;10:537-562.
4. Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ: Primary role of the HLA class II DRB1*0301 allele in Graves' disease. Am J Med Genet 2000;95:432-437.
5. Yanagawa T, Mangklabruks A, Chang YB, Okamoto Y, Fisfalen ME, Curran PG, DeGroot LJ: Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1993;76:1569-1574.
6. Maciel LM, Rodrigues SS, Dibbern RS, Navarro PA, Donadi EA: Association of the HLA-DRB1* 0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid 2001;11:31-35.
7. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423:506-511.
8. Pociot F: CTLA4 gene and autoimmune endocrinopathies: A new marker? J Endocrinol Invest 2002;25:1001-1005.
9. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ: CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1995;80:41-45.
10. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, McCarthy MI, Kendall-Taylor P, Pearce SH: The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 1999;8:1195-1199.
11. Okamoto Y, Yanagawa T, Fisfalen ME, DeGroot LJ: Proliferative responses of peripheral blood mononuclear cells from patients with Graves' disease to synthetic peptide epitopes of human thyrotropin receptor. Thyroid 1994;4:37-42.
12. Oosterwegel MA, Greenwald RJ, Mandelbrot DA, Lorsbach RB, Sharpe AH: CTLA-4 and T cell activation. Curr Opin Immunol 1999;11:294-300.
13. Reiser H, Stadecker MJ: Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 1996;335:1369-1377.
14. Lindsten T, Lee KP, Harris ES, Petryniak B, Craighead N, Reynolds PJ, Lombard DB, Freeman GJ, Nadler LM, Gray GS, et al: Characterization of CTLA-4 structure and expression on human T cells. J Immunol 1993;151:3489-3499.
15. Tomer Y, Davies TF: Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 2003;24:694-717.
16. Sharpe AH, Abbas AK: T-cell costimulation - biology, therapeutic potential, and challenges. N Engl J Med 2006;355:973-975.
17. Mäurer M, Loserth S, Kolb-Mäurer A, Ponath A, Wiese S, Kruse, Rieckmann P: A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 2002;54:1-8.
18. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ: CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 2000;165:6606-6611.
19. Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y: Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun 2003;4:586-593.
20. Kotsa K, Watson PF, Weetman AP: A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf) 1997;46:551-554.
21. Akamizu T, Sale MM, Rich SS, Hiratani H, Noh JY, Kanamoto N, Saijo M, Miyamoto Y, Saito Y, Nakao K, Bowden DW: Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid 2000;10:851-858.
22. Nisticò L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA: The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 1996;5:1075-1080.
23. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K: CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 1997;82:143-146.
24. Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, Saruta T: CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 1997;7:843-846.
25. Heward JM, Allahabadia A, Armitage M, Hattersley A, Dodson PM, Macleod K, CarrSmith J, Daykin J, Daly A, Sheppard MC, Holder RL, Barnett AH, Franklyn JA, Gough SC: The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab 1999;84:2398-2401.
26. Park YJ, Chung HK, Park DJ, Kim WB, Kim SW, Koh JJ, Cho BY: Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 2000;10:453-459.
27. Nithiyananthan R, Heward JM, Allahabadia A, Franklyn JA, Gough SC: Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 2002;12:3-6.
28. Tomer Y, Greenberg DA, Barbesino G, Concepcion E, Davies TF: CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 2001;86:1687-1693.
29. Kinjo Y, Takasu N, Komiya I, Tomoyose T, Takara M, Kouki T, Shimajiri Y, Yabiku K, Yoshimura H: Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene. J Clin Endocrinol Metab 2002;87:2593-2596.
30. Wang PW, Liu RT, Juo SH, Wang ST, Hu YH, Hsieh CJ, Chen MH, Chen IY, Wu CL: Cytotoxic T lymphocyte-associated molecule-4 polymorphism and relapse of Graves' hyperthyroidism after antithyroid withdrawal. J Clin Endocrinol Metab 2004;89:169-173.
31. Yung E, Cheng PS, Fok TF, Wong GW: CTLA-4 gene A-G polymorphism and childhood Graves' disease. Clin Endocrinol (Oxf) 2002;56:649-653.
32. Iwama S, Ikezaki A, Kikuoka N, Kim HS, Matsuoka H, Yanagawa T, Sato H, Hoshi M, Sakamaki T, Sugihara S: Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves' disease in Japanese children. Horm Res 2005;63:55-60.
33. Ikegami H, Awata T, Kawasaki E, Kobayashi T, Maruyama T, Nakanishi K, Shimada A, Amemiya S, Kawabata Y, Kurihara S, Tanaka S, Kanazawa Y, Mochizuki M, Ogihara T: The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J Clin Endocrinol Metab 2006;91:1087-1092.
34. Young-Min S, Vaidya B: CTLA4 exon 1 polymorphism, rheumatoid arthritis and autoimmune endocrinopathy. Clin Rheumatol 2004;23:568-569.
35. Fukazawa T, Yanagawa T, Kikuchi S, Yabe I, Sasaki H, Hamada T, Miyasaka K, Gomi K, Tashiro K: CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients. J Neurol Sci 1999;171:49-55.
36. Cho HJ, Chung JH, Kim IS, Kim HJ, Cho SH, Ki CS, Kim JW: Lack of a genetic association between the CTLA-4 gene and Graves' disease in Koreans. Thyroid 2006;16:237-241.
37. Djilali-Saiah I, Larger E, Harfouch-Hammoud E, Timsit J, Clerc J, Bertin E, Assan R, Boitard C, Bach JF, Caillat-Zucman S: No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM. Diabetes 1998;47:125-127.
38. Chen QY, Nadell D, Zhang XY, Kukreja A, Huang YJ, Wise J, Svec F, Richards R, Friday KE, Vargas A, Gomez R, Chalew S, Lan MS, Tomer Y, Maclaren NK: The human leukocyte antigen HLA DRB3 *020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. J Clin Endocrinol Metab 2000;85:1545-1549.
39. Maalej A, Bougacha N, Rebai A, Bellassouad M, Ayadi-Makni F, Abid M, Jouida J, Makni H, Ayadi H: Lack of linkage and association between autoimmune thyroid diseases and the CTLA-4 gene in a large Tunisian family. Hum Immunol 2001;62:1245-1250.